Agilent Cytation 9 Cell Imaging Multimode Reader, or equivalent instrument

The U.S. Food and Drug Administration, through its Office of Acquisition and Grant Services, is conducting a market survey to gather information on the availability of an Agilent Cytation 9 Cell Imaging Multimode Reader or an equivalent instrument for use at its National Center for Toxicological Research in Jefferson, Arkansas. This sources sought notice is not a solicitation and no contract will be awarded based on responses; it is purely for market research purposes to inform future procurement decisions. Respondents must provide detailed technical information demonstrating their ability to deliver a turn-key solution consisting of a newly manufactured instrument with configurable upright and inverted microscopy and filter- and monochromator-based multimode microplate reading, along with automated high-throughput image acquisition and analysis capabilities for multi-well plate formats. The system must include comprehensive data analysis software for quantitative and qualitative analysis, as well as add-on modules for application-specific imaging tasks. All hardware, software, computers, and components must be newly manufactured with no used, refurbished, or demonstration equipment permitted. The contractor must provide a complete installation by factory-certified service personnel, ensuring all system modules start up properly and are correctly connected. Delivery, installation, and on-site operator training for three to five users must be completed within 60 days of contract award, and the solution must include a minimum one-year warranty from the date of government acceptance, covering troubleshooting, replacement parts, system updates, labor, travel, and on-site training—none of which may be separately priced. A trade-in requirement exists for an existing Agilent BioTek Cytation 3 System with serial number 160920B located in Building 14-1027, and the contractor must assume full costs for its packaging and shipping while also possessing an active, verified trade-in program agreement with Agilent Technologies capable of providing a manufacturer-backed credit of at least 43.1% as a pricing concession. Responses must include the respondent’s business name, SAM number, business size status, contact information, country of manufacture, GSA or Best in Class contract details if applicable, and, for large businesses, information on subcontracting opportunities for small businesses. All submissions must be sent via email by June 22, 2026, to the designated point of contact without inclusion of weblinks or any proprietary, classified, or sensitive information, and no reimbursement will be provided for respondent costs. Compliance with Buy American and Made in America requirements must be addressed by disclosing the place of manufacture.